Research Papers

25 of 1710 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Interacting and joint effects of triglyceride-glucose index (TyG) and body mass index on stroke risk and the mediating …
Huo RR; Liao Q; Zhai L; You XM; Zuo YL.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Early left ventricular microvascular dysfunction in diabetic pigs: a longitudinal quantitative myocardial perfusion CMR…
Jiang L; Yan WF; Zhang L; Xu HY; Guo YK; Li ZL; Liu KL; Zeng LM; Li Y; Yang ZG.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Triglyceride-glucose index as a suitable non-insulin-based insulin resistance marker to predict cardiovascular events i…
He J; Song C; Yuan S; Bian X; Lin Z; Yang M; Dou K.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Characterizing the metabolic divide: distinctive metabolites differentiating CAD-T2DM from CAD patients.
Liu Y; Liu JE; He H; Qin M; Lei H; Meng J; Liu C; Chen X; Luo W; Zhong S.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Associations of combined polygenic risk score and glycemic status with atrial fibrillation, coronary artery disease and…
Kim J; Kim D; Bae HJ; Park BE; Kang TS; Lim SH; Lee SY; Chung YH; Ryu JW; Lee MY; Yang PS; Joung B.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Primary aldosteronism and lower-extremity arterial disease: a two-sample Mendelian randomization study.
Hu J; Zeng Q; Chen X; Luo W; Tang Z; Mei M; Zhao W; Du Z; Liu Z; Li Q; Cheng Q; Yang S.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Early insulin resistance in normoglycemic low-risk individuals is associated with subclinical atherosclerosis.
Iglesies-Grau J; Garcia-Alvarez A; Oliva B; Mendieta G; García-Lunar I; Fuster JJ; Devesa A; Pérez-Herreras C; Fernández-Ortiz A; Brugada R; Ibanez B; Fernandez-Jimenez R; Fuster V.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose up…
Cinti F; Leccisotti L; Sorice GP; Capece U; D'Amario D; Lorusso M; Gugliandolo S; Morciano C; Guarneri A; Guzzardi MA; Mezza T; Capotosti A; Indovina L; Ferraro PM; Iozzo P; Crea F; Giordano A; Giaccari A.
Cardiovasc Diabetol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
The triglyceride glucose index trajectory is associated with hypertension: a retrospective longitudinal cohort study.
Xin F; He S; Zhou Y; Jia X; Zhao Y; Zhao H.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Association of metabolic dysfunction-associated fatty liver disease with systemic atherosclerosis: a community-based cr…
Zhang Y; Xia Z; Cai X; Su X; Jin A; Mei L; Jing J; Wang S; Meng X; Li S; Wang M; Wei T; Wang Y; He Y; Pan Y.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Obesity indices and the risk of total and cardiovascular mortality among people with diabetes: a long-term follow-up st…
Lu CY; Chen HH; Chi KH; Chen PC.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disea…
Di Marco M; Scilletta S; Miano N; Marrano N; Natalicchio A; Giorgino F; Di Mauro S; Filippello A; Scamporrino A; Tribulato P; Bosco G; Di Giacomo Barbagallo F; Scicali R; Milluzzo A; Ballirò T; Frittitta L; Castellino P; Purrello F; Piro S; Di Pino A.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Triglyceride-glucose index is associated with a higher risk of stroke in a hypertensive population.
Zhang N; Chi X; Zhou Z; Song Y; Li S; Xu J; Li J.
Cardiovasc Diabetol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Opposite causal effects of birthweight on myocardial infarction and atrial fibrillation and the distinct mediating path…
Kong L; Wang Y; Ye C; Dou C; Liu D; Xu M; Zheng J; Zheng R; Xu Y; Li M; Zhao Z; Lu J; Chen Y; Wang W; Liu R; Bi Y; Wang T; Ning G.
Cardiovasc Diabetol (Unknown)
Published: 2023
4/6 Transparent
Code Funding Declared
Effects of exenatide on coronary stent's endothelialization in subjects with type 2 diabetes: a randomized controlled t…
Santos-Pardo I; Witt N; Angerås O; Nyström T.
Cardiovasc Diabetol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Safety and efficacy of bempedoic acid: a systematic review and meta-analysis of randomised controlled trials.
De Filippo O; D'Ascenzo F; Iannaccone M; Bertaina M; Leone A; Borzillo I; Ravetti E; Solano A; Pagliassotto I; Nebiolo M; Bruno F; Giacobbe F; Muscoli S; Monticone S; Brizzi MF; Biondi Zoccai G; De Ferrari GM.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coron…
Tao S; Yu L; Li J; Xie Z; Huang L; Yang D; Tan Y; Zhang W; Huang X; Xue T.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study.
Cui C; Liu L; Zhang T; Fang L; Mo Z; Qi Y; Zheng J; Wang Z; Xu H; Yan H; Yue S; Wang X; Wu Z.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam…
Chen J; Arshi B; Waqas K; Lu T; Bos D; Ikram MA; Uitterlinden AG; Kavousi M; Zillikens MC.
Cardiovasc Diabetol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Sodium-glucose cotransporter-2 inhibition for heart failure with preserved ejection fraction and chronic kidney disease…
Mentz RJ; Brunton SA; Rangaswami J.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Association of glycemic variability with death and severe consciousness disturbance among critically ill patients with …
Cai W; Li Y; Guo K; Wu X; Chen C; Lin X.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Association between insulin resistance and uncontrolled hypertension and arterial stiffness among US adults: a populati…
Tan L; Liu Y; Liu J; Zhang G; Liu Z; Shi R.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Triglyceride-glucose index in the prediction of clinical outcomes after successful recanalization for coronary chronic …
Yang Y; Ma M; Zhang J; Jin S; Zhang D; Lin X.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Triglycerides/HDL cholesterol ratio and type 2 diabetes incidence: Panasonic Cohort Study 10.
Yuge H; Okada H; Hamaguchi M; Kurogi K; Murata H; Ito M; Fukui M.
Cardiovasc Diabetol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
High BMI and the risk for incident type 1 Diabetes Mellitus: a systematic review and meta-analysis of aggregated cohort…
Nitecki M; Gerstein HC; Balmakov Y; Tsur E; Babushkin V; Michaeli T; Afek A; Pinhas-Hamiel O; Cukierman-Yaffe T; Twig G.
Cardiovasc Diabetol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared